Interleukin-2 Inducible Tyrosine Kinase Inhibitors (MannKind)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameInterleukin-2 Inducible Tyrosine Kinase Inhibitors (MannKind)
Drug Alias NameITK Inhibitors (MannKind)MKC-242844MKC-243067
ClassificationSmall molecules
Mechanisms of ActionAnticancer protein kinase inhibitorsIL-2 release inhibitorsTyrosine-protein kinase ITK/TSK inhibitors
TargetsTyrosine-protein kinase ITK/TSK
Therapy Area/IndicationsLymphoma, T-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMannKind Corp
Active IndicationsN/A
Inactive IndicationsLymphoma, T-Cell

Other Information

ATC CodeN/A
Related LinksN/A